In human thyroid carcinomas, constitutive signaling of the MAP kinase cascade contributes to the development of thyroid cancer promoted by activated RAS and BRAF onco-proteins and that this occurs, at least in part, by compromising the Skp2-dependent degradation pathway [30]. Here, SKP2 is linked to thyroid gland carcinoma.